Navigation Links
Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
Date:8/29/2007

er clinical trial in early 2008 in mild-to-moderate AD patients. This study will focus on several measures of efficacy, including ADAS-Cog, safety and the role of insulin regulation in AD.

About Ketasyn(TM) (AC-1202)

Brain imaging techniques performed on aging adults and Alzheimer's patients reveal a dramatically decreased uptake of glucose, the brain's preferred source of energy. Ketasyn(TM) (AC-1202) is an orally available compound that is efficiently metabolized by the liver into ketone bodies, an alternative energy source that the brain can utilize when glucose metabolism is compromised. Ketasyn has disease modifying potential in AD and a number other neurodegenerative diseases characterized by decreased glucose use in the brain, which is known as neuronal hypometabolism.

About Accera, Inc.

Based in Broomfield, CO, Accera, Inc. is a privately held biotechnology company focused on developing novel drugs for neurodegenerative diseases. The company's lead candidate, AC-1202, is a first-in-class molecule that has recently completed Phase II clinical trials for Alzheimer's disease and Age- Associated Memory Impairment. Accera has other small molecule compounds in its product pipeline for a range of other neurodegenerative diseases including Parkinson's disease and Huntington's disease. For more information, visit: http://www.accerapharma.com.

PRESS CONTACT:

Richard Lewis Communications, Inc.

Meghan Feeks

mfeeks@rlcinc.com

(212) 827-0020


'/>"/>
SOURCE Accera, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
2. Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus
3. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
4. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
5. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
10. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
11. First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, MammographyEquipment-AGlobalMarketP...164330/Mammography-Equipment---A-Global-Market-Per...inindustrializedaswellasdevelopingnationsisaprinci...lobally,escalatingawarenessaboutbreastcancerhasall...
(Date:11/25/2009)...ALTHAM,Mass.,Nov.25/PRNewswire/--AccordingtoMillen...technologymarketintelligence,thenearly$3billionUSm...dgrowthoverthenextfiveyearsdespitetherecenteconomi...portfindsthatthismarketwillremainhighlydynamicover...izeddevicesinpreviouslyunderservedsegmentsofthetra...
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, PainManagement-GlobalTrends ,,...ment---Global-Trends.html ,, Widespreadavailab...cs,andtheadventofnewdrugshaveacceleratedthepaceofg...dreimbursementstructurecontinuetoshapedemandforser...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Carefxs New Referral Management Solution Increases Hospital Referral Volume Enhances Collaboration Among Specialists PCPs and Patients 54153 1Carefxs New Referral Management Solution Increases Hospital Referral Volume Enhances Collaboration Among Specialists PCPs and Patients 54153 2Carefxs New Referral Management Solution Increases Hospital Referral Volume Enhances Collaboration Among Specialists PCPs and Patients 54153 3Carefxs New Referral Management Solution Increases Hospital Referral Volume Enhances Collaboration Among Specialists PCPs and Patients 54153 4Health Market Science Announces Commercial Release of CompleteSpend V2 5 54151 1Health Market Science Announces Commercial Release of CompleteSpend V2 5 54151 2Health Market Science Announces Commercial Release of CompleteSpend V2 5 54151 3Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 1Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 2
...November 11, 2008 at 9:00 am ET, SOUTH SAN FRANCI...) today announced that the ACTIVE-1 Phase 3 trial,...icin, narrowly missed its,primary endpoint of redu...llowing bunionectomy surgery at four to 32 hours p...nt (p=0.004) from four to 48 hours,post-surgery. T...
...r,Pharmaceuticals Corp. ("Raptor" or the "Company"... the Company has entered into an agreement with,th...d,Angers") of France to,evaluate Raptor,s propriet...teamine") in a Phase II clinical trial in patients...,Angers has received a grant from the,Programme Ho...
Other Medicine Technology:Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 2Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 3Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 4Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 2Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 3Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 4Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 6
(Date:11/27/2009)... Multi-purpose bilingual colorin...ed for use by the business community to educate - ...subjects from Safety issues to Dinosuars to ABC,S ... Saint Louis, MO (PRWEB) November 27, 2009 -- ...onics or toys to keep them busy any hour of the da...
(Date:11/26/2009)... PRINCETON,N.J.,Nov.27/PRNewswire/--Thediabetespop...t25yearsandannualmedicalspendingonthediseaseisproj...dingtoastudypublishedintheDecemberissueof Diabetes...CDP),aprogramofNovoNordisk,commissionedtheanalysis...totheforecast,thenumberofAmericanslivingwithdiabet...
(Date:11/26/2009)...t a bigger thrill when on an emotional rollercoast...ealthDay News) -- Call it the fear factor meets th...hat spectators -- especially those who root for th...if it,s a closely contested match and victory was ...pair. , Chew on that this Thanksgiving weekend ...
(Date:11/26/2009)... Benton Communications announces...owth system for retailers struggling to make an ec...) November 26, 2009 -- Flu fears is the type of ch...e emergency room, according to Dr. David Benton, b...ased business growth system – The Rfactor I...
(Date:11/25/2009)... EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/-- ...ncedthatthecompanywillhosttwoinvestoreventsinDecem...9:00a.m.CT/10:00a.m.ET ,, Principalinvestigat...mibinrelapsedand/orrefractorymultiplemyeloma,asfea...alMeetingandExpositioninNewOrleans,LA.Theteleconfe...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...unched to Provide Information and Product Acquisit...adlines of,the recent tragedies caused by Communit...g Solutions, LLC, part of the Key Medical Group of...ducts to combat and kill these superbugs. The webs...
...ld be part of routine medical care, researchers su...) -- Rates of HIV testing in the United States hav...d of all Americans ever having been screened for t... drug users -- have been tested within the past ye...
...Y and Southfield, MI October 23, 2007 The Juveni...st charitable funder of type 1 diabetes research, ...utical Research Laboratories (HPRL) to support the... , We are thrilled to be partnering with Housey P...
...bright Children,s Foundation is unveiling Get Fit,...nline program designed to reduce,obesity in teens ...ditions,such as blindness, amputation, renal failu...as they work to improve their,eating and exercise ...
...fits Market Experiences Largest Increase Since 199...cans received dental benefits than the year before...enefits enrollment, according to the 2007,Joint De...the top reason cited by consumers for not going to...
...-- Cancer therapies save and prolong many lives, b...a debilitating toll on patients, mental and emotio...ot dealt with during oncology treatment. Cancer c...ir ability to follow through on treatment, and fal...
Other Medicine News:Health News:Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not 2Health News:Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not 3Health News:Many at Risk for HIV Not Being Tested 2Health News:Many at Risk for HIV Not Being Tested 3Health News:JDRF partners with Housey Pharmaceutical Research Laboratories 2Health News:MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS 2Health News:Population Covered by Dental Benefits Increases 2Health News:Cancer care providers need to proactively address patients' psychological and social needs 2Health News:Cancer care providers need to proactively address patients' psychological and social needs 3
3M™ Precise™ Vista Disposable Skin Stapler
...he Eppendorf Reference Series 2000 Pipette is a sy...ompact and robust design, and superior operating c... to operate the measuring stroke and blow-out as w...pipette/tip" system ensures utmost accuracy and pr...
Pipetman F200
Ovation BioNatural Pipette, two-stroke, fixed volume, 100L
Medicine Products: